Results 111 to 120 of about 28,830 (241)

Optimization of solid phase extraction for simultaneous quantification of efavirenz and levonorgestrel in wastewater using HPLC

open access: yesFrontiers in Environmental Science
This study aims to optimize the SPE parameters for purification and preconcentration of EFV and LVG to enable optimum detection and quantification by LC-20 Prominence High-Performance Liquid Chromatography (HPLC) system.
E. P. Munzhelele   +4 more
doaj   +1 more source

Safety of efavirenz in the first trimester of pregnancy

open access: green, 2011
Nathan Ford   +2 more
openalex   +2 more sources

48 week bone marker changes with Dolutegravir (DTG) plus Abacavir/Lamivudine (ABC/3TC) vs. Tenofovir/Emtricitabine/Efavirenz (EFV/TDF/FTC): the SINGLE trial [PDF]

open access: gold, 2014
Yazdan Yazdanpanah   +9 more
openalex   +1 more source

Effect of Efavirenz on the Pharmacokinetics of SHR6390 in Healthy Volunteers

open access: yes
Jin Wang, Chaoying Hu, Lan Zhang Department of Pharmacy, Phase I Clinical Trial Center, Xuanwu Hospital Capital Medical University, Beijing, People’s Republic of ChinaCorrespondence: Chaoying Hu; Lan Zhang, Email hucarol@126.com; xwzhanglan@126 ...
Hu C, Zhang L, Wang J
core  

Efavirenz Intoxication Due to Slow Hepatic Metabolism

open access: yes, 2017
We describe a human immunodeficiency virus-positive woman who presented with severe psychosis while she was receiving therapy with efavirenz. Her plasma efavirenz level was excessively high.
Hasse, B.   +3 more
core  

Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA [PDF]

open access: bronze, 2010
Heather Hsu   +10 more
openalex   +1 more source

Desenvolvimento e validação de metodologia para a certificação da pureza enantiomérica do Efavirenz

open access: diamond, 2004
CECÍLIA SUMIE FUZITA WATANABE   +6 more
openalex   +2 more sources

Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results [PDF]

open access: gold, 2013
for the SUPPORT Study Team   +12 more
openalex   +1 more source

Home - About - Disclaimer - Privacy